Home » Topics » Regulatory » Patents

Patents
RSS

Invictus Oncology patents CSF1R inhibitors

Sep. 3, 2018

Capella BioSience describes antibodies targeting LIGHT

Sep. 3, 2018

Bristol-Myers Squibb patents receptor-interacting serine/threonine-protein kinase 1 inhibitors

Aug. 31, 2018

Astellas Pharma discloses KRAS Gly12Cys mutant inhibitors

Aug. 30, 2018

TGF-beta decoy receptors patented by Tessa Therapeutics

Aug. 29, 2018

Biogen describes new mitogen-activated protein kinase kinase kinase 5 inhibitors

Aug. 29, 2018

Aryl hydrocarbon receptor antagonists discovered at Phenex Pharmaceuticals

Aug. 28, 2018

Shire Human Genetic Therapies patents TGF-beta inhibitors

Aug. 28, 2018

Mutabilis SAS synthesizes prodrugs of beta-lactamase inhibitors

Aug. 28, 2018

Seoul National University patents 4'-phosphopantetheinyl transferase inhibitors

Aug. 27, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026